Community
Company
News
Contact Us
Sign in

Please select the option that best describes you:

Topics: Radiation Oncology

When is it appropriate to treat splenic metastasis with radiation?

What dose/ fractionation is recommended?

Related Questions

Given results of the RADICALS trials, is LT-ADT standard of care for salvage prostate RT?

Do you recommend neoadjuvant 177Lu-PNT2002 followed by MDT per the LUNAR trial as your preferred treatment approach for oligorecurrent prostate cancer, as opposed to MDT and PSMA-radioligand therapy used as temporally separate treatments?

Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?

Would you offer liver re-irradiation in a Child-Pugh A patient with oligo-metastatic colon cancer to the liver, diagnosed > 10 years prior with previous TACE + SBRT to same liver metastasis ~5 years ago?

How would you approach treatment failures with squamous cell carcinoma-keratoacanthoma-type lesions that did not respond to a standard SRT regimen after many sessions?

Would you consider elective neck nodal irradiation for a large >5 cm head and neck extramedullary solitary plasmacytoma arising from the nasal cavity?

How do the results of INSEMA and SOUND impact the decision of omitting SLND in young women with breast cancer and offering adjuvant RT to patients who would otherwise be candidates for omission?

What adjuvant treatment approach would you recommend for a patient with early-stage MSI-high gastric cancer who received neoadjuvant ipilimumab (×2) and nivolumab (×6) per the NEONIPIGA regimen, followed by R0 resection with no pathologic response?

How do you decide on lung constraints for SBRT after whole lung radiation for persistent nodules?

Would you offer any adjuvant therapy for a young patient with anal cancer s/p definitive chemoradiation and R0 resection with significant residual disease?

Copyright © 2025 theMednet
All Rights Reserved.